慢性阻塞性肺病治疗新进展  

The New Therapy of Chronic Obstructive Pulmonary Disease

作　　者：王军[1] 王菲[2] 时莎[2] 冯学威[3] 

机构地区：[1]中国医科大学附属盛京医院,沈阳110004 [2]中国医科大学,七年制沈阳110001 [3]中国医科大学附属盛京医院呼吸内科,沈阳110004

出　　处：《医学综述》2010年第6期873-875,共3页Medical Recapitulate

摘　　要：慢性阻塞性肺病新疗法促进抗炎效能以及影响疾病的进程。联合用药,类固醇敏感性的恢复,选择性磷酸二酯酶4抑制剂和选择性p38-α-激酶抑制剂以及组织蛋白酶C等新近提出的疗法,为有效控制疾病提供了新思路。在慢性阻塞性肺病非药物疗法上的创新——自我管理,为患者提供信息和指南,以及必要的技能来增加信心,对于病人的健康有潜在的影响,对经济效益产生正面效应。The novel therapies for chronic obstructive pulmonary disease （COPD） , which are improved antiinflammatory activity and potential to ＇affect disease progression. The new proposals, such as combined therapy, restoration of steroid sensitivity, selective phosphodicsterasc-4 （ PDE-4 ） inhibitor and selective p38-α-kinase inhibitor and Cathepsin C,provide new approach for the control of COPD. There has been significant innovation in the nonpharmacological management of COPD, that is self-management. Information and guidelines, as well as interventions that provide patients with needed skills to increase their confidence, have potential impact on patients health, and take advantage of economy.

关 键 词：慢性阻塞性肺病 药物治疗 抗炎 自我管理 

分 类 号：R453[医药卫生—治疗学]